Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sandoz
Sandoz
Novartis unit teams up with medical marijuana producer, marking milestone for pharma
Stat
Tue, 12/18/18 - 12:53 pm
Novartis
Sandoz
Medical Marijuana
Tilray Canada
Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
Fierce Pharma
Thu, 12/6/18 - 01:37 pm
Novartis
Sandoz
generics
Symjepi
EpiPens
Teva Pharmaceutical
Mylan
Pear, Sandoz launch first FDA-approved digital therapeutic
BioCentury
Wed, 11/21/18 - 10:00 am
Pear Therapeutics
Sandoz
digital therapeutics
substance abuse
reSET
Novartis 'completely committed' to Sandoz, has no split-off plan
Yahoo/Reuters
Thu, 11/15/18 - 11:20 am
Novartis
Sandoz
generics
Novartis' Sandoz calls it quits on Rituxan biosimilar after FDA requests more data
Fierce Pharma
Mon, 11/5/18 - 11:53 am
Novartis
Sandoz
FDA
biosimilars
Roche
Rituxan
Novartis abandons effort for U.S. approval of biosimilar rituximab
Yahoo/Reuters
Sat, 11/3/18 - 12:39 pm
Novartis
Sandoz
rituximab
biosimilars
Roche
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
RAPS.org
Mon, 10/22/18 - 05:17 pm
Europe
AbbVie
Humira
Amgen
Samsung Bioepis
Mylan Labs
Novartis
Sandoz
Fresenius Kabi
Boehringer Ingelheim
Sandoz free to launch Humira biosimilar in Europe following AbbVie deal
Pharmaforum
Fri, 10/12/18 - 10:24 am
Novartis
Sandoz
AbbVie
Humira
biosimilars
Europe
Amgen, Sandoz begin biosimilar trial with top-selling Enbrel at stake
Biopharma Dive
Thu, 09/13/18 - 11:19 pm
Amgen
Sandoz
Enbrel
biosimilars
Novartis
Novartis sells parts of Sandoz for $1bn
Pharmaforum
Thu, 09/6/18 - 09:40 am
Novartis
Sandoz
M&A
dermatology
Aurobindo
Omeros Prevails in Patent Dispute With Sandoz
CP Wire
Thu, 07/26/18 - 11:24 am
Omeros
Sandoz
Novartis
patents
Omidria
Omeros Prevails in Patent Dispute With Sandoz
Thu, 07/26/18 - 09:12 am
Omeros
Omidria
Sandoz
lawsuits
patent lawsuits
Novartis steps in to compete with Mylan’s Epipen
Drug Delivery Business News
Mon, 07/2/18 - 09:27 am
Adamis Pharmaceuticals
Novartis
Sandoz
Symjepi
Mylan
EpiPens
Novartis receives EU approval for biosimilar Zessly
Reuters
Thu, 05/24/18 - 09:38 pm
Novartis
Sandoz
biosimilars
Europe
Zessly
Aurobindo bids $1.6B for Novartis' U.S. dermatology generics: report
Fierce Pharma
Mon, 05/7/18 - 10:53 pm
Aurobindo
Novartis
Sandoz
M&A
dermatology
India
Impax Laboratories Agrees to Settle Antitrust Lawsuit
CP Wire
Mon, 04/30/18 - 06:46 pm
Impax Laboratories
Solodyn
antitrust
Medicis
Lupin
Sandoz
No more Mr Nice Guy: GlaxoSmithKline is coming out of its corner swinging
Endpoints
Thu, 02/8/18 - 11:18 am
GSK
R&D
Pharma CEOs
Emma Walmsley
Advair
Novartis
Sandoz
Gilead Sciences
HIV
FDA rejects Novartis’ Advair generic, leaving GSK without rival
Drug Delivery Business News
Thu, 02/8/18 - 09:17 am
FDA
Novartis
Advair
generics
GSK
Sandoz
Novartis aims for US approval of Humira biosimilar
Biopharma Dive
Wed, 01/17/18 - 09:55 pm
Novartis
Humira
biosimilars
AbbVie
Sandoz
Allergan says court affirms patent loss to Sandoz on eye drug
Reuters
Sat, 12/23/17 - 11:33 pm
Allergan
patents
Sandoz
generics
Combigan
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »